FRANKLIN LAKES, N.J., May 15, 2017 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the following upcoming investor healthcare conferences:
Bank of America Merrill Lynch 2017 Healthcare Conference
May 17, 2017
11:40 a.m. EDT
Jefferies 2017 Global Healthcare Conference
June 8, 2017
9:00 a.m. EDT
Goldman Sachs 38th Annual Global Healthcare Conference
June 13, 2017
11:40 a.m. EDT
Live webcasts of BD's presentations can be accessed on the BD corporate website at www.bd.com/investors. They will be available for replay for a period of seven days after each conference.
BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures, and support the management of diabetes. The company partners with organizations around the world to address some of the most challenging global health issues. BD has nearly 50,000 associates across 50 countries who work in close collaboration with customers and partners to help enhance outcomes, lower health care delivery costs, increase efficiencies, improve health care safety and expand access to health. For more information on BD, please visit bd.com.
Kristen Cardillo, Communications – 858-847-5657
Monique Dolecki, Investor Relations - 201-847-5378
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/bd-to-present-at-investor-healthcare-conferences-300457836.html
SOURCE BD (Becton, Dickinson and Company)